The CES group responded significantly better than the other 2 groups over the 3 month follow-up. Only the CES group showed significant carry-over effects in finger temperature.

5
Brovar, Alan
1984

25

cocaine abusers

A follow-up of the 3 groups from 6 to 8 months later showed that no CES patients had returned for treatment, while 50% of the CES refusers and 39% of the controls had recidivated.

anxiety, depression, insomnia outpatients unresponsive to medications

Those who had beneficial results maintained them throughout the 6 month follow-up.

inducing sleep

Follow-up of patients up to 1 year after treatment has not revealed any harmful side effects.

psychotherapy outpatients

3 patients showed continued improvement for 2 weeks to 2 months.

20

generalized stress >1 year, unresponsive to meds

1 week follow-up measures in the CES group showed significant carryover effects in EMG and HR, but were not significant at the .05 level for finger temperature or capacitance.

dental patients

From the results obtained during 1 year of treating a variety of patients requiring a broad scope of dental treatments, CES was found to provide a safe, noninvasive, readily acceptable, adjunctive analgesic modality to maintain patient comfort through the majority of dental procedures for most patients.

A: 20

B: 9

A: Follow-up has continued for 8-12 months after treatment and has revealed no relapse.

B: The asthmatic attacks stopped completely in 3 children and 4 months later the children felt well without taking any drugs.

62

A follow-up measure 2 weeks post study found that 11 of the 13 variables were still significantly improved in the treatment group.

17

anxiety and insomnia patients

Despite largely negative findings several subjects reported “a remarkable improvement” in their symptoms 2-3 weeks after CES.

anxiety outpatients

On 6-8 month follow-up, 73% of the patients were “well satisfied” with their treatment and had no significant regression or other anxiety disorder, 18% were “satisfied” but had some problem with anxiety since they stopped the treatment, and 9% chose not to respond, had significant symptoms since stopping the treatment, or in 1 case, “was not satisfied.”

hospitalized alcohol and polysubstance abusers

Of a 50% response to follow-up, 78.5% were addiction-free (80.3% of drug addicts) 1 to 8 years after CES, with an average time in rehabilitation of only 16 days. Alcohol, marijuana and cigarette use were decreased in 64%. Diminished drug use was reported in 76% of recidivists. 17% had 1 treatment after CES (another CES treatment or other hospital treatment), and 1% had 2 treatments. This compares favorably with a U.S. government survey showing that 26% to 43% had repeat treatments every year after the initial treatment, for up to 6 years.

psychiatric outpatients with anxiety, depression, ADD

On 18 month follow-up the patients performed as well or better than in the original study.

10

insomnia patients

All differences found were maintained at the 2 week and 2 year follow-up.

50

3 months after discharge from hospital 9 schizophrenics (32.1%) but only 3 patients with affective psychosis (13.6%) presented a “good outcome” (full remission).

insomnia patients

Some patients maintained their improvement 4 months later, while others had partial return of symptoms. None regressed completely.

156

eczema and neuro- dermatitis patients

12 months follow-up revealed that the positive effects of CES was sufficiently stable.